Array BioPharma Inc. and GT Advanced Technologies Inc. Analysis Reports: (NASDAQ: ARRY), (NASDAQ: GTAT)
Array BioPharma Inc. (NASDAQ: ARRY) traded in the range of $5.97 and $6.56 during its latest trading session, which is also its 52 weeks high price point. The stock had opened at $5.99 and is at $6.15, up 3.19 percent from its previous close of $5.96, with above average shares volume. Array BioPharma has traded 2.1 million shares so far and its MACD chart shows bullish trend.
View full press release